Results 161 to 170 of about 1,253,356 (303)

Celluloepidemiology-A paradigm for quantifying infectious disease dynamics on a population level. [PDF]

Sci Adv
Ha MK, Postovskaya A, Kuznetsova M, Meysman P, Van Deuren V, Van Ierssel S, De Reu H, Schippers J, Peeters K, Besbassi H, Heyndrickx L, Willems B, Mariën J, Bartholomeus E, Vercauteren K, Beutels P, Van Damme P, Lion E, Vlieghe E, Laukens K, Coenen S, Naesens R, Ariën KK, Ogunjimi B.   +23 more
europepmc   +1 more source

Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen, Henrik Horwitz, Ida M. Heerfordt, Elisabeth Framke, Melinda Magyari   +4 more
wiley   +1 more source

Evolving infectious disease dynamics shape school-based intervention effectiveness. [PDF]

Nat Commun
Perez-Saez J, Bellon M, Lessler J, Berthelot J, Hodcroft EB, Michielin G, Pennacchio F, Lamour J, Laubscher F, L'Huillier AG, Posfay-Barbe KM, Maerkl SJ, Guessous I, Azman AS, Eckerle I, Stringhini S, Lorthe E, SEROCoV-Schools study group.   +17 more
europepmc   +1 more source

Efgartigimod Combined With Steroid Treatment for HAM/TSP: A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive neurological disorder with limited treatment options. We report a 54‐year‐old female with decade‐long, progressive HAM/TSP, previously refractory to rituximab, who experienced worsening spastic paraparesis and neurogenic bladder dysfunction.
Jiahui Zeng, Wotu Tian, Jingran Yang, Yanping Yang, Li Cao, Xinghua Luan   +5 more
wiley   +1 more source

Machine Learning and Artificial Intelligence for Infectious Disease Surveillance, Diagnosis, and Prognosis. [PDF]

Viruses
Cheah BCJ, Vicente CR, Chan KR.
europepmc   +1 more source

Analysis of the Longitudinal Behavior of Serum Levels of Soluble Flt1 and Placental Growth Factor in Pregnant Patients With Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective This study analyzed longitudinal trajectories of soluble Flt1 (sFlt1) levels, placenta growth factor (PlGF) levels, and sFlt1:PlGF ratios in a cohort of pregnant patients with systemic lupus erythematosus (SLE). Methods Blood samples were collected (14–18, 24–26, 30–32, 34–36, and 38–40 weeks), stored at −80°C, and evaluated for serum levels ...
Nilson R. de Jesús, Guilherme R. de Jesús, Marcela I. Lacerda, Flávia C. dos Santos, Jeane de S Nogueira, Luiz Cristóvão Porto, Evandro S. F. Coutinho, Evandro M. Klumb   +7 more
wiley   +1 more source

Past, present, and future: a situational analysis of infectious disease modelling in Thailand. [PDF]

Lancet Reg Health Southeast Asia
Sittimart M, Rachatan C, Muenkaew P, Dabak SV.   +3 more
europepmc   +1 more source

INFECTION AND IMMUNITY, WITH SPECIAL REFERENCE TO THE PREVENTION OF INFECTIOUS DISEASES

, 1904
GEORGE M. STERNBERG
openalex   +2 more sources

Metabolic Consequences of Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry, Emily Sheng, Joshua F. Baker   +2 more
wiley   +1 more source

When passion is not enough: the waning of the infectious disease workforce. [PDF]

mSphere
Leeds JA.
europepmc   +1 more source